Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pinto

Showing results (801-810 of 859) with videos related to

Pageof 86
Sort By:
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Journal of Physical Activity & Health|June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After VaccinationFabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Global Heart|August 12, 2021
Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart FederationÁlvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, et al.
Cancer Discovery|October 10, 2019
PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast CancerCarlotta Costa, Ye Wang, Amy Ly, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
The American Journal of Clinical Nutrition|May 21, 2021
Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort studyBruna Z Reis, Alan L Fernandes, Lucas P Sales, et al.
Journal of Pharmaceutical Sciences|October 5, 2007
N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerationsKan He, Mingxin Qian, Harvey Wong, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Pageof 86

Showing results (801-810 of 859) with videos related to

Sort By:
Pageof 86
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Journal of Physical Activity & Health|June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After VaccinationFabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Global Heart|August 12, 2021
Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart FederationÁlvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, et al.
Cancer Discovery|October 10, 2019
PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast CancerCarlotta Costa, Ye Wang, Amy Ly, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
The American Journal of Clinical Nutrition|May 21, 2021
Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort studyBruna Z Reis, Alan L Fernandes, Lucas P Sales, et al.
Journal of Pharmaceutical Sciences|October 5, 2007
N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerationsKan He, Mingxin Qian, Harvey Wong, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patientsBruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Pageof 86